News
The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...
Aug 5 - Vertex Pharmaceuticals (NASDAQ:VRTX) shares dropped nearly 17% on Tuesday after its experimental pain medication, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback